NOhep Villager: Hepatitis Outbreaks’ National Organization for Reform

Hepatitis Outbreaks’ National Organization for Reform – HONOReform – began as a response to a tragedy caused when healthcare providers failed to follow injection safety practices when providing treatment. HONOReform protects patients through safeguarding the medical injection process and encourages healthcare providers and consumers to follow fundamental injection safety practices – from manufacturing through disposal.

What do you plan to do at your booth in the NOhep Village?

We’ll be engaging delegates in conversations about injection safety. We will draw delegates in with attractive signage and a selfie station, photos from which may be uploaded to social media. Educational handouts in each of the injection safety areas (medical injections, drug diversion, needlestick injuries and harm reduction) will be available. We’ll also be giving away a flashdrive in the shape of a syringe with lots of injection safety resources pre-loaded on the drive.

What will make your booth stand out?

We will give away flashdrives loaded with injection safety resources. Resources include materials that educate about medical injection safety, drug diversion prevention, needlestick injury prevention and harm reduction (injection safety) for people who inject drugs.

What are you most looking forward to about the Global Hepatitis Summit?

Learning from people from other countries about their viral hepatitis prevention successes and challenges.

How will exhibiting in the NOhep Village benefit your organisation?

It will raise our visibility as experts in all areas of injection safety as a means of preventing the transmission of viral hepatitis.

How have you worked with the scientific community in the past?

We have partnered with the CDC for many years in support of the One & Only Campaign. We have also served as the patient voice for the Safe Injection Global Network of the World Health Organization.

For more information on HONOReform’s work, visit their website, Twitter, Facebook or YouTube.